PEP-Therapy

PEP-Therapy is a biotechnology company developing first-class peptides for targeted therapy of critical diseases, with an initial focus on cancer. PEP-Therapy develops Cell Penetrating and Interfering Peptides (CP&IP) for intracellular delivery of targeted therapies. These active compounds penetrate cells and block relevant intracellular protein-protein interactions, thereby inhibiting key pathological mechanisms.